A pair of San Gabriel Valley biomed companies have announced progress in technologies that can be used to fight Covid-19.
Company will seek FDA approval soon
Shares of Temple City-based genetic testing company Fulgent Genetics Inc. soared March 17 as it announced the launch of a new genetic test for detecting the Covid-19 virus.
Hospitals will share resources, research
Cedars-Sinai Health System and Pasadena Hospital, also known as Huntington Memorial Hospital, have agreed to share medical and research resources.
Cal State LA facility will anchor bioscience corridor
Local bioscience entrepreneur Alan Horsager has been named the first director for LA BioSpace, the soon-to-open bioscience incubator at Cal State Los Angeles.
Lincare purchase increases pharmacy footprint
Cerritos-based KabaFusion has expanded by acquiring the home infusion operations of Lincare Holdings Inc. of Clearwater, Fla.
Sawtelle diagnostic imaging company RadNet Inc. announced March 11 it has agreed to buy Cambridge, Mass.-based radiology artificial intelligence company DeepHealth Inc. in a stock deal.
Firm will expand telemedicine services
Cloudbreak Health, an El Segundo-based interpreter service for the medical industry, has received $10 million in funding from Columbia Partners Private Capital of Bethesda, Md.
Shares of Pasadena-based Puma Biotechnology Inc. fell after the company revealed that sales of its breast cancer treatment drug, Nerlynx, declined during the fourth quarter.
Company anticipates disruption in operations for quarter, year
Count downtown-based nutrition supplement company Herbalife Nutrition Ltd. as another company feeling the impact of the rapid spread of the Covid-19 coronavirus throughout China.
Institute acquires surgery center in Marina del Rey
Hoag Memorial Hospital Presbyterian, one of Orange County’s largest hospital and health care networks, is entering the Los Angeles County market.
Nestlé service will boost company’s supplement
The world’s largest food and beverage company has agreed to flex more of its marketing muscle for a product from Westwood-based nutrition company ChromaDex Inc.
The FDA must decide within six months whether to approve the drug, known as KTE-X19
Deal with Aimmune could bring up to $400 million before royalties
Monrovia-based biopharmaceutical company Xencor Inc. announced it has granted a license to Bay Area-based Aimmune Therapeutics Inc.
Managed care insurer projects $17 billion in revenue for 2020
With the release of fourth-quarter and full-year 2019 earnings, Molina issued a forecast of premium revenue growth for this year of 7.4% to about $17.4 billion.
Biotechnology company stays quiet amid speculation about run-up
After a year of lackluster and disappointing performance, shares of Westwood-based biopharmaceutical company Puma Biotechnology Inc. mysteriously shot up 81% Feb. 4 and 5 on some of its heaviest trading volume in years.